Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-20

FDA Approved: EFAVIRENZ — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for efavirenz from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

SUPPL AP for EFAVIRENZ (EFAVIRENZ)